Sun Pharma Hits 52-Week High, Gains Nearly 25% Over Past Year
Sun Pharmaceutical Industries Ltd has reached a 52-week high, trading around Rs 2,000 to Rs 2,033, with gains of approximately 7-9% over the past month and nearly 25% over the past year. This performance outpaces the broader NIFTY and Nifty Pharma indices, which have seen declines or modest gains. The stock has risen for five consecutive sessions, reflecting sustained investor interest amid a broader market rally where several other BSE 100 stocks also hit 52-week highs.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (52/100). Lens Score 37/100.
Outlets measured: businessstandard, economictimes. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (50–55/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
economictimes broke this story on 30 Jul, 12:23 pm. Other outlets followed.